News

NCVTC to develop of host-directed antivirals for COVID-19

The selected candidates with anti-coronavirus activity will be subjected to study their molecular mechanism of action, besides examining generation of potential drug-resistant virus variants.

Read More

Jun 05, 2020

By : Team ABLE

IIT Alumni launches MegaLab, a global Genetic Testing Lab initiative

A Global Competition is being launched to finalize the operating, technology and funding partners for the MegaLab Mumbai initiative.

Read More

Jun 04, 2020

By : Team ABLE

CEPI grants $14.1 million to consortium of Bharat Biotech and IVI for Chikungunya vaccine work

CEPI will fund the consortium with up to US$14.1 million( Rs 106 crore) for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya.

Read More

Jun 04, 2020

By : Team ABLE

Serum Institute commits to ramp up HPV vaccines supply

On the eve of the Global Vaccine Summit 2020, five manufacturers committed to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world. Manufacturers target to immunize at least 84 million girls in Gavi countries

Read More

Jun 04, 2020

By : Team ABLE

Stempeutics India, Novumcella Japan partner for Buerger's Disease drug

Stempeutics plans to commercialize Stempeucel product for the same indication in Japan in partnership with Novumcella.

Read More

Jun 03, 2020

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights